ReviewPharmaceuticals (Basel, Switzerland)2022

Research Progress on Therapeutic Targeting of Cancer-Associated Fibroblasts to Tackle Treatment-Resistant NSCLC.

Chenxin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.